A pilot study to evaluate the safety and efficacy of BLI801 vs. placebo in constipated adults.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
52
Advanced Clinical Research Institute
Anaheim, California, United States
Jupiter Research
Jupiter, Florida, United States
United Medical Research
New Smyrna Beach, Florida, United States
Long Island GI Research Group
Great Neck, New York, United States
percentage of patients experiencing a bowel movement within 3 hours of the first study medication dose
Time frame: 3 hours
percentage of patients experiencing a complete/satisfactory bowel movement (BM) within 3 hours of first dose
Time frame: 3 hours
serum chemistry
Time frame: 7 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.